Current trends in triblock copolymer-based multifunctional nanotheranostics for cancer treatment

Triblock copolymers hold significant potential for advanced cancer treatment owing to their tunable and multifunctional nature. Their responsiveness to various stimuli enables precise drug delivery and controlled release specifically at tumor sites, thereby reducing systemic toxicity. The strategic design of dual and triple-responsive systems offers refined control over drug release kinetics, thereby addressing multidrug resistance challenges. Within a singular platform, triblock copolymers can accommodate drugs, siRNA, antibodies, and imaging agents, facilitating combined diagnosis and therapy. By capitalizing on triblock self-assembly and receptor-specific ligands, advanced targeting strategies can be developed to enhance selective drug delivery to cancer cells. Nonetheless, the realization of their full potential necessitates addressing challenges in precise synthesis, comprehensive characterization, and successful translation to clinical applications. Ongoing research aimed at optimizing triblock design and properties remains imperative to unlock their transformative capabilities in the realm of cancer nanomedicine. A thorough understanding of these copolymers and their behavior will pave the way for revolutionizing the landscape of cancer treatment and tailoring therapies to individual patients for improved outcomes.